FREDIANI BRUNO | Professor page

Gentileschi, S., Gaggiano, C., Placido, F., Terribili, R., Cometi, L., Lopalco, G., et al. (2026). A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian study. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 18 [10.1177/1759720x261442376]. - view more
Vitale, A., Caggiano, V., Sbalchiero, J., Lopalco, G., Tufan, A., Ragab, G., et al. (2026). Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry. SEMINARS IN ARTHRITIS AND RHEUMATISM, 80 [10.1016/j.semarthrit.2026.153030]. - view more
Ramonda, R., Lorenzin, M., Carletto, A., Chimenti, M.S., Manara, M., Cozzi, G., et al. (2026). Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis. FRONTIERS IN PHARMACOLOGY, 17 [10.3389/fphar.2026.1757110]. - view more
Calabrese, L., D'Onghia, M., Cartocci, A., Hinojosa-Azaola, A., Torres-Ruiz, J., Lopalco, G., et al. (2026). Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry. RHEUMATOLOGY [10.1093/rheumatology/keaf512]. - view more
Grasso, D., Balloni, V., Bianchi, E., Mazzon, A., Bardelli, M., Iacomelli, G., et al. (2026). Plasma and urinary NMR metabolic profiling of the phenylalanine-tyrosine pathway in nitisinone-treated alkaptonuria: comparison of two dosing regimens and identification of a candidate pharmacodynamic biomarker. MOLECULAR GENETICS AND METABOLISM, 149(1-2) [10.1016/j.ymgme.2026.110255]. - view more

All publications